This webinar has already taken place. However, you can watch a recording of it below.
Originally aired on March 5, 2015
This “Open Call for Technology” aims to attract promising new Technology Innovators, Entrepreneurs, Established Companies and Scientists to present your science DIRECTLY to relevant Subject Matter Experts (SMEs) in the biotech and pharmaceutical industries.
Through the Technology Evaluation Consortium™ (TEC), we can enable the collaborative evaluation and rapid adoption of promising new technologies for use in life sciences research and development.
The Technology Evaluation Consortium is an innovative, collaborative program run by One Million Solutions in Health™ (OMSiH), a non-profit organization, dedicated to improving and accelerating life sciences R&D and outcomes. This program has a proven track record benefiting innovators, biopharmaceutical companies and healthcare, with more than a decade of pre-competitive and non-competitive analysis of promising new technologies, products and services.
This Open Call for Technology is a NEW INITIATIVE — and we would like you to get in on the ground floor of this opportunity.
One Million Solutions in Health has been charged with the responsibility of taking the Technology Evaluation Consortium to a new level, and attracting a wider selection of new technologies. Our goal is to help the creators of new science, and the industry, realize the many benefits of your scientific advances, in an accelerated manner.
During this complimentary webinar, you will learn more about the opportunity for selected Technology Innovators/Providers to benefit from participation in this successful program. You will also have the opportunity to hear directly from one of our technology innovators, Quantitative Medicine, on how the Technology Evaluation Consortium helped shape their technology, increase their customer base and generate market exposure.
The benefits realized by participating in the Technology Evaluation Consortium are diverse and far-reaching. Beneficial outcomes reported by past Technology Innovator participants have included:
> Expert Feedback: Receiving direct feedback from knowledgeable Subject Matter Experts (SMEs) who can positively influence adoption and use of your technology is priceless.
> Credibility: Achieving credible third-party evaluation and validation of your technology makes it more attractive and less risky to the biopharmaceutical industry and/or to investors.
> Collaboration: The collaborative program builds trust, is more robust, yields better outcomes, and lays a solid foundation for future cooperation.
> Market Penetration & Growth: Build a deep understanding of your technology with top pharmaceutical companies by working collaboratively.
> Brand Equity: Brand knowledge in the minds of key industry players increases the strategic and financial value of the brand and, consequently, increases the value of your business.
Co-Founder, Chairman, President & CEO
Chief Scientific Officer
Dawn Van Dam
President and CEO
One Million Solutions in Health™